Qube Research & Technologies Ltd - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 36 filers reported holding LANTERN PHARMA INC in Q1 2024. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q2 2024$10
-99.9%
2
-99.9%
0.00%
Q1 2024$14,978
+166322.2%
1,702
+85000.0%
0.00%
Q4 2023$9
+28.6%
20.0%0.00%
Q3 2023$720.00%
Other shareholders
LANTERN PHARMA INC shareholders Q1 2024
NameSharesValueWeighting ↓
CM Management, LLC 80,000$373,6000.34%
Redmond Asset Management, LLC 39,635$185,0950.06%
Westside Investment Management, Inc. 11,500$53,7050.01%
Meridian Wealth Management, LLC 14,945$69,7930.01%
NewEdge Advisors, LLC 157,124$733,7900.01%
Sigma Planning Corp 28,400$132,6280.00%
DAVENPORT & Co LLC 63,814$298,0110.00%
WOLFF WIESE MAGANA LLC 600$2,8020.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 28,791$134,4540.00%
Avantax Planning Partners, Inc. 11,640$54,3590.00%
View complete list of LANTERN PHARMA INC shareholders